Please enable JS

Regulation & Policy (Pharma & Healthcare)

Title Published Pages Region Price
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016 Apr 1 2017 111 Global $1,500.00
Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design Mar 1 2017 117 Global $2,995.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam Jul 1 2016 147 Vietnam $1,995.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia Jul 1 2016 238 Saudi Arabia $1,995.00
Partnerships, Licensing, Investments and M&A Deals and Trends for May 2016 in Pharmaceuticals Jul 1 2016 93 Global $1,000.00
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2016 Jun 3 2016 132 Global $1,500.00
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2016 in Pharmaceuticals Jun 1 2016 98 Global $1,000.00
Partnerships, Licensing, Investments and M&A Deals and Trends for March 2016 in Pharmaceuticals May 1 2016 97 Global $1,000.00
Partnerships, Licensing, Investments and M&A Deals and Trends for January 2016 in Pharmaceuticals Mar 1 2016 108 Global $1,000.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - UK Mar 1 2016 253 United Kingdom $1,995.00
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015 Feb 11 2016 148 Global $1,500.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia Feb 1 2016 178 Indonesia $1,995.00
Partnerships, Licensing, Investments and M&A Deals and Trends for December 2015 in Pharmaceuticals Feb 1 2016 99 Global $1,000.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India Jan 11 2016 235 India $1,995.00
Methicillin-Resistant Staphylococcus aureus (MRSA) - Japan Drug Forecast and Market Analysis to 2024 Dec 16 2015 321 Japan $4,995.00
Methicillin-Resistant Staphylococcus aureus (MRSA) - Current and Future Players Dec 16 2015 125 Global $2,995.00
Methicillin-Resistant Staphylococcus aureus (MRSA) - 5EU Drug Forecast and Market Analysis to 2024 Dec 16 2015 328 Europe $6,995.00
Methicillin-Resistant Staphylococcus aureus (MRSA) - US Drug Forecast and Market Analysis to 2024 Dec 16 2015 320 USA $4,995.00
Hemophilia A and B Recombinant Factor Replacement Therapy - Current and Future Players Dec 11 2015 84 Global $2,995.00
Hemophilia A and B Recombinant Factor Replacement Therapy - Argentina Drug Forecast and Market Analysis to 2024 Dec 11 2015 229 Argentina $4,995.00
Hemophilia A and B Recombinant Factor Replacement Therapy - US Drug Forecast and Market Analysis to 2024 Dec 11 2015 229 USA $4,995.00
Hemophilia A and B Recombinant Factor Replacement Therapy - 5EU Drug Forecast and Market Analysis to 2024 Dec 11 2015 242 Europe $6,995.00
Hemophilia A and B Recombinant Factor Replacement Therapy - Japan Drug Forecast and Market Analysis to 2024 Dec 11 2015 229 Japan $4,995.00
Gastric and Gastroesophageal Junction Adenocarcinoma - China Drug Forecast and Market Analysis to 2024 Dec 9 2015 270 China $4,995.00
Gastric and Gastroesophageal Junction Adenocarcinoma - US Drug Forecast and Market Analysis to 2024 Dec 9 2015 267 USA $4,995.00
Gastric and Gastroesophageal Junction Adenocarcinoma - 5EU Drug Forecast and Market Analysis to 2024 Dec 9 2015 283 Europe $6,995.00
Gastric and Gastroesophageal Junction Adenocarcinoma - Japan Drug Forecast and Market Analysis to 2024 Dec 9 2015 269 Japan $4,995.00
Gastric and Gastroesophageal Junction Adenocarcinoma - Current and Future Players Dec 9 2015 122 Global $2,995.00
Partnerships, Licensing, Investments and M&A Deals and Trends for October 2015 in Pharmaceuticals Dec 1 2015 100 Global $1,000.00
Frontier Pharma: Obesity - Identifying and Commercializing First-in-Class Innovation Oct 1 2015 87 Global $6,995.00